DOI:
10.1055/s-00000144
Zeitschrift für Orthomolekulare Medizin
LinksClose Window
References
Henderson ST et al.
Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled, multicenter trial.
Nutr Metab 2009;
6: 31
Access:
We do not assume any responsibility for the contents of the web pages of other providers.